APA (7th ed.) Citation

L, K., A, A., E, B., P, B., N, M., AM, W., . . . O, H. (2026). Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial. Diagnostics (Basel, Switzerland), 16(11), . https://doi.org/10.3390/diagnostics16111649

Chicago Style (17th ed.) Citation

L, Kølner-Augustson, Altraja A, Bendstrup E, Bradding P, Makholm N, Wilson AM, Simonsen U, and Hilberg O. "Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial." Diagnostics (Basel, Switzerland) 16, no. 11 (2026). https://doi.org/10.3390/diagnostics16111649.

MLA (9th ed.) Citation

L, Kølner-Augustson, et al. "Senicapoc in Patients with Idiopathic Pulmonary Fibrosis or Other Progressive Fibrotic Interstitial Lung Diseases: Protocol for a Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Trial." Diagnostics (Basel, Switzerland), vol. 16, no. 11, 2026, https://doi.org/10.3390/diagnostics16111649.